Lupin Acquires Southern Cross Pharma In Australia.

Lupin Ltd.’s Australia-based subsidiary has agreed to buy Southern Cross Pharma Pty Ltd. to build on its existing portfolio of prescription generics, over-the-counter and specialty products. Lupin will acquire 100% shares of Southern Cross Pharma, according to an exchange filing. That would give its wholly-owned arm Generic Health access to more than 60 registered products having sales of over A$

The deal is expected to be concluded in the next five-six months. The cost of acquisition is undisclosed, and will be arrived at subject to post-closing adjustments.



BloombergQuint